ArticleJournal of the European Academy of Dermatology and Venereology : JEADV2026

Translating 6-year trial safety data of upadacitinib in atopic dermatitis into clinical practice.

Lian F van der Gang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.